Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
42
IQV Quote, Financials, Valuation and Earnings
Last price:
$163.29
Seasonality move
:
1.26%
Day range:
$156.16 - $159.80
52-week range:
$134.65 - $252.88
Dividend yield:
0%
P/E ratio:
21.61x
P/S ratio:
1.86x
P/B ratio:
4.59x
Volume:
1.5M
Avg. volume:
2.1M
1-year change:
-31.91%
Market cap:
$27.4B
Revenue:
$15.4B
EPS (TTM):
$7.34
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $11.4B | $13.9B | $14.4B | $15B | $15.4B | |
| Revenue Growth (YoY) | 2.44% | 22.14% | 3.86% | 3.98% | 2.81% | |
| Cost of Revenues | $7.5B | $9.2B | $9.4B | $9.7B | $10B | |
| Gross Profit | $3.9B | $4.6B | $5B | $5.2B | $5.4B | |
| Gross Profit Margin | 33.97% | 33.45% | 34.89% | 34.96% | 34.89% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.8B | $2B | $2.1B | $2.1B | $2B | |
| Other Inc / (Exp) | -- | $84M | -$61M | $34M | $23M | |
| Operating Expenses | $3.1B | $3.2B | $3.2B | $3.2B | $3.1B | |
| Operating Income | $783M | $1.4B | $1.8B | $2.1B | $2.3B | |
| Net Interest Expenses | $410M | $369M | $403M | $636M | $623M | |
| EBT. Incl. Unusual Items | $373M | $1.1B | $1.4B | $1.5B | $1.7B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $72M | $163M | $260M | $101M | $301M | |
| Net Income to Company | $308M | $971M | $1.1B | $1.4B | $1.4B | |
| Minority Interest in Earnings | -$29M | -$5M | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $279M | $966M | $1.1B | $1.4B | $1.4B | |
| Basic EPS (Cont. Ops) | $1.46 | $5.05 | $5.82 | $7.39 | $7.57 | |
| Diluted EPS (Cont. Ops) | $1.43 | $4.95 | $5.72 | $7.29 | $7.49 | |
| Weighted Average Basic Share | $191.3M | $191.4M | $187.6M | $183.8M | $181.3M | |
| Weighted Average Diluted Share | $195M | $195M | $190.6M | $186.3M | $183.4M | |
| EBITDA | $2.1B | $2.8B | $2.9B | $3.3B | $3.5B | |
| EBIT | $789M | $1.5B | $1.8B | $2.1B | $2.3B | |
| Revenue (Reported) | $11.4B | $13.9B | $14.4B | $15B | $15.4B | |
| Operating Income (Reported) | $783M | $1.4B | $1.8B | $2.1B | $2.3B | |
| Operating Income (Adjusted) | $789M | $1.5B | $1.8B | $2.1B | $2.3B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.4B | $3.6B | $3.7B | $3.7B | $3.8B | |
| Revenue Growth (YoY) | 23.78% | 4.66% | 2.35% | 2.33% | 2.46% | |
| Cost of Revenues | $2.3B | $2.3B | $2.4B | $2.4B | $2.5B | |
| Gross Profit | $1.1B | $1.2B | $1.3B | $1.3B | $1.3B | |
| Gross Profit Margin | 32.74% | 34.89% | 34.34% | 34.6% | 33.9% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $442M | $488M | $513M | $508M | $508M | |
| Other Inc / (Exp) | $4M | -$17M | $9M | -$26M | -$48M | |
| Operating Expenses | $765M | $743M | $766M | $772M | $773M | |
| Operating Income | $351M | $502M | $488M | $521M | $525M | |
| Net Interest Expenses | $98M | $85M | $135M | $155M | $154M | |
| EBT. Incl. Unusual Items | $257M | $400M | $362M | $340M | $323M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $44M | $71M | $71M | $49M | $61M | |
| Net Income to Company | $217M | $325M | $289M | $288M | $249M | |
| Minority Interest in Earnings | -$5M | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $212M | $325M | $289M | $288M | $249M | |
| Basic EPS (Cont. Ops) | $1.11 | $1.71 | $1.56 | $1.58 | $1.42 | |
| Diluted EPS (Cont. Ops) | $1.09 | $1.68 | $1.53 | $1.56 | $1.40 | |
| Weighted Average Basic Share | $191.5M | $190M | $185.8M | $181.9M | $175.7M | |
| Weighted Average Diluted Share | $194.9M | $193.4M | $188.6M | $184.3M | $177.4M | |
| EBITDA | $679M | $741M | $756M | $770M | $753M | |
| EBIT | $356M | $486M | $503M | $506M | $488M | |
| Revenue (Reported) | $3.4B | $3.6B | $3.7B | $3.7B | $3.8B | |
| Operating Income (Reported) | $351M | $502M | $488M | $521M | $525M | |
| Operating Income (Adjusted) | $356M | $486M | $503M | $506M | $488M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $12B | $14B | $14.5B | $15.1B | $15.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $8B | $9.3B | $9.5B | $9.8B | $10.1B | |
| Gross Profit | $4B | $4.8B | $5B | $5.3B | $5.4B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.8B | $2B | $2.1B | $2B | $2B | |
| Other Inc / (Exp) | $2M | $63M | -$35M | -$1M | $1M | |
| Operating Expenses | $3.1B | $3.2B | $3.2B | $3.2B | $3.1B | |
| Operating Income | $927M | $1.6B | $1.8B | $2.1B | $2.3B | |
| Net Interest Expenses | $404M | $356M | $453M | $656M | $622M | |
| EBT. Incl. Unusual Items | $528M | $1.3B | $1.3B | $1.4B | $1.7B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $99M | $190M | $260M | $79M | $313M | |
| Net Income to Company | $434M | $1.1B | $1.1B | $1.4B | $1.3B | |
| Minority Interest in Earnings | -$25M | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $409M | $1.1B | $1.1B | $1.4B | $1.3B | |
| Basic EPS (Cont. Ops) | $2.14 | $5.65 | $5.66 | $7.43 | $7.42 | |
| Diluted EPS (Cont. Ops) | $2.10 | $5.55 | $5.56 | $7.32 | $7.34 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $2.2B | $2.8B | $2.9B | $3.3B | $3.4B | |
| EBIT | $937M | $1.6B | $1.8B | $2.1B | $2.3B | |
| Revenue (Reported) | $12B | $14B | $14.5B | $15.1B | $15.5B | |
| Operating Income (Reported) | $927M | $1.6B | $1.8B | $2.1B | $2.3B | |
| Operating Income (Adjusted) | $937M | $1.6B | $1.8B | $2.1B | $2.3B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.4B | $3.6B | $3.7B | $3.7B | $3.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.3B | $2.3B | $2.4B | $2.4B | $2.5B | |
| Gross Profit | $1.1B | $1.2B | $1.3B | $1.3B | $1.3B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $442M | $488M | $513M | $508M | $508M | |
| Other Inc / (Exp) | $4M | -$17M | $9M | -$26M | -$48M | |
| Operating Expenses | $765M | $743M | $766M | $772M | $773M | |
| Operating Income | $351M | $502M | $488M | $521M | $525M | |
| Net Interest Expenses | $98M | $85M | $135M | $155M | $154M | |
| EBT. Incl. Unusual Items | $257M | $400M | $362M | $340M | $323M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $44M | $71M | $71M | $49M | $61M | |
| Net Income to Company | $217M | $325M | $289M | $288M | $249M | |
| Minority Interest in Earnings | -$5M | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $212M | $325M | $289M | $288M | $249M | |
| Basic EPS (Cont. Ops) | $1.11 | $1.71 | $1.56 | $1.58 | $1.42 | |
| Diluted EPS (Cont. Ops) | $1.09 | $1.68 | $1.53 | $1.56 | $1.40 | |
| Weighted Average Basic Share | $191.5M | $190M | $185.8M | $181.9M | $175.7M | |
| Weighted Average Diluted Share | $194.9M | $193.4M | $188.6M | $184.3M | $177.4M | |
| EBITDA | $679M | $741M | $756M | $770M | $753M | |
| EBIT | $356M | $486M | $503M | $506M | $488M | |
| Revenue (Reported) | $3.4B | $3.6B | $3.7B | $3.7B | $3.8B | |
| Operating Income (Reported) | $351M | $502M | $488M | $521M | $525M | |
| Operating Income (Adjusted) | $356M | $486M | $503M | $506M | $488M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.8B | $1.4B | $1.2B | $1.4B | $1.7B | |
| Short Term Investments | $88M | $111M | $93M | $120M | $141M | |
| Accounts Receivable, Net | $1.2B | $1.3B | $1.3B | $1.5B | $1.4B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $159M | $156M | $151M | $141M | $154M | |
| Other Current Assets | $563M | $521M | $561M | $546M | $592M | |
| Total Current Assets | $5.1B | $4.8B | $5B | $5.6B | $5.8B | |
| Property Plant And Equipment | $953M | $903M | $863M | $819M | $773M | |
| Long-Term Investments | $162M | $164M | $162M | $239M | $374M | |
| Goodwill | $12.7B | $13.3B | $13.9B | $14.6B | $14.7B | |
| Other Intangibles | $5.2B | $4.9B | $4.8B | $4.8B | $4.5B | |
| Other Long-Term Assets | $386M | $491M | $472M | $455M | $520M | |
| Total Assets | $24.6B | $24.7B | $25.3B | $26.7B | $26.9B | |
| Accounts Payable | $581M | $621M | $645M | $709M | $736M | |
| Accrued Expenses | $1.4B | $1.4B | $1.7B | $1.9B | $2B | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $242M | $207M | $152M | $294M | $193M | |
| Total Current Liabilities | $4.6B | $5.2B | $5.6B | $6.5B | $7B | |
| Long-Term Debt | $12.4B | $12B | $12.6B | $13B | $12.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $18.3B | $18.6B | $19.6B | $20.6B | $20.8B | |
| Common Stock | $11.1B | $3M | $10.9B | $3M | $3M | |
| Other Common Equity Adj | -$205M | -$406M | -$727M | -$867M | -$1B | |
| Common Equity | $6B | $6B | $5.8B | $6.1B | $6.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $279M | -- | -- | -- | -- | |
| Total Equity | $6.3B | $6B | $5.8B | $6.1B | $6.1B | |
| Total Liabilities and Equity | $24.6B | $24.7B | $25.3B | $26.7B | $26.9B | |
| Cash and Short Terms | $1.9B | $1.5B | $1.3B | $1.5B | $1.8B | |
| Total Debt | $12.5B | $12.1B | $12.7B | $13.7B | $14B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.3B | $1.4B | $1.5B | $1.4B | $1.7B | |
| Short Term Investments | $97M | $106M | $104M | $131M | $136M | |
| Accounts Receivable, Net | $1.2B | $1.2B | $1.4B | $1.4B | $1.4B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $159M | $162M | $165M | $173M | $166M | |
| Other Current Assets | $593M | $455M | $460M | $442M | $558M | |
| Total Current Assets | $5.6B | $4.8B | $5.3B | $5.7B | $5.9B | |
| Property Plant And Equipment | $909M | $938M | $845M | $791M | $768M | |
| Long-Term Investments | $162M | $162M | $201M | $263M | $383M | |
| Goodwill | $12.4B | $13.5B | $14B | $14.5B | $15B | |
| Other Intangibles | $4.9B | $4.9B | $4.8B | $4.7B | $4.5B | |
| Other Long-Term Assets | $380M | $528M | $468M | $476M | $485M | |
| Total Assets | $24.5B | $25B | $25.7B | $26.6B | $27.3B | |
| Accounts Payable | $2.8B | $2.8B | $3.1B | $3.5B | $3.6B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $216M | $189M | $157M | $207M | $319M | |
| Total Current Liabilities | $4.9B | $5.2B | $6.7B | $6.4B | $7.2B | |
| Long-Term Debt | $12.1B | $12.5B | $11.8B | $12.8B | $13.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $18.2B | $19.1B | $19.8B | $20.2B | $21.3B | |
| Common Stock | $11.1B | $10.7B | $10.9B | $11B | $3M | |
| Other Common Equity Adj | -$376M | -$419M | -$731M | -$911M | -$978M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $284M | -- | -- | -- | $8M | |
| Total Equity | $6.2B | $5.9B | $5.9B | $6.3B | $6B | |
| Total Liabilities and Equity | $24.5B | $25B | $25.7B | $26.6B | $27.3B | |
| Cash and Short Terms | $2.4B | $1.5B | $1.6B | $1.6B | $1.9B | |
| Total Debt | $12.2B | $12.6B | $13.2B | $13.5B | $14.3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $308M | $971M | $1.1B | $1.4B | $1.4B | |
| Depreciation & Amoritzation | $1.3B | $1.3B | $1.1B | $1.1B | $1.1B | |
| Stock-Based Compensation | $95M | $170M | $194M | $217M | $206M | |
| Change in Accounts Receivable | $255M | -$138M | -$421M | -$388M | $182M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2B | $2.9B | $2.3B | $2.1B | $2.7B | |
| Capital Expenditures | $616M | $640M | $674M | $649M | $602M | |
| Cash Acquisitions | -$167M | -$1.5B | -$1.3B | -$915M | -$867M | |
| Cash From Investing | -$796M | -$2.1B | -$2B | -$1.6B | -$1.4B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2.8B | $2.8B | $3.6B | $6.4B | $1.7B | |
| Long-Term Debt Repaid | -$2.5B | -$2.7B | -$2.7B | -$5.6B | -$1.1B | |
| Repurchase of Common Stock | -$447M | -$406M | -$1.2B | -$992M | -$1.4B | |
| Other Financing Activities | -$68M | -$840M | -$31M | -$131M | -$17M | |
| Cash From Financing | -$217M | -$1.2B | -$329M | -$382M | -$878M | |
| Beginning Cash (CF) | $837M | $1.8B | $1.4B | $1.2B | $1.4B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $946M | -$396M | -$75M | $164M | $394M | |
| Ending Cash (CF) | $1.8B | $1.4B | $1.2B | $1.4B | $1.7B | |
| Levered Free Cash Flow | $1.3B | $2.3B | $1.6B | $1.5B | $2.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $217M | $325M | $289M | $288M | $249M | |
| Depreciation & Amoritzation | $323M | $255M | $253M | $264M | $265M | |
| Stock-Based Compensation | $32M | $30M | $75M | $56M | $72M | |
| Change in Accounts Receivable | $342M | $54M | -$107M | $65M | $128M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $867M | $508M | $417M | $522M | $568M | |
| Capital Expenditures | $149M | $177M | $164M | $145M | $142M | |
| Cash Acquisitions | -$20M | -$436M | -$25M | -$166M | -$147M | |
| Cash From Investing | -$176M | -$613M | -$222M | -$314M | -$305M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.8B | $950M | $475M | $275M | $2.3B | |
| Long-Term Debt Repaid | -$1.8B | -$324M | -$139M | -$318M | -$2.1B | |
| Repurchase of Common Stock | -$62M | -$403M | -$129M | -- | -$375M | |
| Other Financing Activities | -$43M | -$12M | -$62M | -$3M | -$12M | |
| Cash From Financing | -$168M | $144M | $87M | -$106M | -$258M | |
| Beginning Cash (CF) | $1.8B | $1.4B | $1.2B | $1.4B | $1.7B | |
| Foreign Exchange Rate Adjustment | -$32M | -$18M | -$4M | -$34M | $33M | |
| Additions / Reductions | $523M | $39M | $282M | $102M | $5M | |
| Ending Cash (CF) | $2.3B | $1.4B | $1.5B | $1.4B | $1.7B | |
| Levered Free Cash Flow | $718M | $331M | $253M | $377M | $426M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $434M | $1.1B | $1.1B | $1.4B | $1.3B | |
| Depreciation & Amoritzation | $1.3B | $1.2B | $1.1B | $1.1B | $1.1B | |
| Stock-Based Compensation | $127M | $168M | $239M | $198M | $222M | |
| Change in Accounts Receivable | $681M | -$426M | -$582M | -$216M | $245M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.7B | $2.6B | $2.2B | $2.3B | $2.8B | |
| Capital Expenditures | $624M | $668M | $661M | $630M | $599M | |
| Cash Acquisitions | -$190M | -$1.9B | -$924M | -$1.1B | -$848M | |
| Cash From Investing | -$822M | -$2.5B | -$1.6B | -$1.7B | -$1.4B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2.8B | $2B | $3.1B | $6.2B | $3.7B | |
| Long-Term Debt Repaid | -$3B | -$1.3B | -$2.5B | -$5.8B | -$2.9B | |
| Repurchase of Common Stock | -$164M | -$747M | -$894M | -$863M | -$1.7B | |
| Other Financing Activities | -$89M | -$809M | -$81M | -$72M | -$26M | |
| Cash From Financing | -$492M | -$923M | -$386M | -$575M | -$1B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.3B | -$880M | $168M | -$16M | $297M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $2B | $1.9B | $1.5B | $1.6B | $2.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $217M | $325M | $289M | $288M | $249M | |
| Depreciation & Amoritzation | $323M | $255M | $253M | $264M | $265M | |
| Stock-Based Compensation | $32M | $30M | $75M | $56M | $72M | |
| Change in Accounts Receivable | $342M | $54M | -$107M | $65M | $128M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $867M | $508M | $417M | $522M | $568M | |
| Capital Expenditures | $149M | $177M | $164M | $145M | $142M | |
| Cash Acquisitions | -$20M | -$436M | -$25M | -$166M | -$147M | |
| Cash From Investing | -$176M | -$613M | -$222M | -$314M | -$305M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.8B | $950M | $475M | $275M | $2.3B | |
| Long-Term Debt Repaid | -$1.8B | -$324M | -$139M | -$318M | -$2.1B | |
| Repurchase of Common Stock | -$62M | -$403M | -$129M | -- | -$375M | |
| Other Financing Activities | -$43M | -$12M | -$62M | -$3M | -$12M | |
| Cash From Financing | -$168M | $144M | $87M | -$106M | -$258M | |
| Beginning Cash (CF) | $1.8B | $1.4B | $1.2B | $1.4B | $1.7B | |
| Foreign Exchange Rate Adjustment | -$32M | -$18M | -$4M | -$34M | $33M | |
| Additions / Reductions | $523M | $39M | $282M | $102M | $5M | |
| Ending Cash (CF) | $2.3B | $1.4B | $1.5B | $1.4B | $1.7B | |
| Levered Free Cash Flow | $718M | $331M | $253M | $377M | $426M | |
Get IQV Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
IQV
Sector
P/E ratio
21.61x
23.88x
PEG ratio
79.10x
0.00x
P/B ratio
4.59x
1.80x
Price / LTM sales
1.86x
1.65x
Growth Metrics
IQV
Sector
Revenue growth
2.46%
4.06%
Earnings growth
-10.26%
7.46%
Revenue (5-year growth)
6.8%
8.01%
Earnings forecast
$2.77
-$0.20
Profitability
IQV
Sector
Profitability FY 2024
$5.4B
$47.5M
Return on invested capital
6.62%
-16.26%
Return on assets
4.96%
-13.27%
Return on equity
20.79%
-18.61%
Earnings Date
Last Earnings Date
May
6
Next Earnings Date
Jul
22
Estimated Next Earnings Date
Aug
5
Balance Sheet
IQV
Sector
Total cash
$1.9B
$35.5M
Short term investments
$141M
$29.7M
Total assets
$26.9B
$106.9M
Long term debt
$14.3B
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
